Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Director/PDMR Shareholding

20 Oct 2011 16:47

RNS Number : 5742Q
BowLeven Plc
20 October 2011
 

20 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Directors' interests

 

The Company announces that on 19 October 2011, pursuant to a conditional placing of 77,500,000 new ordinary shares in the capital of the Company at a placing price of 103 pence each, the following dealings (direct or indirect) by directors of Bowleven took place (in accordance with a derogation granted to the Company in respect of AIM rule 21) pursuant to the conditional placing:-

 

Ronnie Hanna, Non-Executive Chairman of the Company, has agreed to subscribe for 20,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ronnie Hanna's total beneficial shareholding in the Company will be 330,125 shares which at that time will represent approximately 0.11% of the then enlarged issued share capital of the Company.

 

Kevin Hart, Chief Executive Officer of the Company, has agreed to subscribe for 200,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Kevin Hart's total beneficial shareholding in the Company will be 2,190,000 shares which at that time will represent approximately 0.75% of the then enlarged issued share capital of the Company.

 

John Brown, Finance Director of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, John Brown's total beneficial shareholding in the Company will be 122,675 shares which at that time will represent approximately 0.04% of the then enlarged issued share capital of the Company.

 

Ed Willett, Exploration Director of the Company has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Ed Willett's total beneficial shareholding in the Company will be 217,235 shares which at that time will represent approximately 0.07% of the then enlarged issued share capital of the Company.

 

Peter Wilson, Director and General Counsel of the Company, has agreed to subscribe for 25,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Peter Wilson's total beneficial shareholding in the Company will be 277,119 shares which at that time will represent approximately 0.09% of the then enlarged issued share capital of the Company.

 

Tim Sullivan, Non-Executive Director of the Company, has agreed to subscribe for 50,000 ordinary shares in the Company at a price of 103 pence per share. Subject to the allotment of the placing shares on 8 November 2011, Tim Sullivan's total beneficial shareholding in the Company will be 146,745 shares which at that time will represent approximately 0.05% of the then enlarged issued share capital of the Company.

 

The allotment of the new ordinary shares pursuant to the conditional placing is subject to, amongst other things, the required shareholder approval to be sought at the Company's General Meeting being held on Monday 7 November 2011.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

Kevin Hart, Chief Executive

00 44 131 524 5678

Kerry Crawford, Head of Investor Relations

BofA Merrill Lynch

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

00 44 207 404 5959

Natalia Erikssen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGQCUUPGGAU
Date   Source Headline
13th Mar 20074:44 pmRNSAdditional Listing
13th Mar 20077:00 amRNSHolding(s) in Company
7th Mar 200711:22 amRNSHolding(s) in Company
7th Mar 200710:59 amRNSHolding(s) in Company
6th Mar 20072:37 pmRNSAdditional Listing
1st Mar 20072:25 pmRNSIE-2 Well Test Results
23rd Feb 200711:47 amRNSAdditional Listing
23rd Feb 20077:00 amRNSHolding(s) in Company
19th Feb 20079:39 amRNSDrilling Report
14th Feb 20076:33 pmRNSHolding(s) in Company
14th Feb 20076:32 pmRNSHolding(s) in Company
12th Feb 200711:14 amRNSAdditional Listing
8th Feb 20073:52 pmRNSAdditional Listing
7th Feb 20076:19 pmRNSHolding(s) in Company
7th Feb 20076:17 pmRNSHolding(s) in Company
5th Feb 20076:06 pmRNSHolding(s) in Company
31st Jan 20078:45 amRNSTotal Voting Rights
26th Jan 200712:15 pmRNSOffer Unconditional
18th Jan 20073:27 pmRNSDirector/PDMR Shareholding
16th Jan 20076:00 pmRNSHolding(s) in Company
15th Jan 200711:24 amBUSEPT Disclosure
15th Jan 20079:08 amRNSRule 8.3- Bowleven Plc
15th Jan 20077:03 amRNSAcceptances
12th Jan 200711:22 amBUSEPT Disclosure
11th Jan 200712:45 pmRNSRule 8.3- BowLeven PLC
11th Jan 200712:29 pmBUSEPT Disclosure
10th Jan 200711:27 amBUSEPT Disclosure
10th Jan 200710:58 amRNSRule 8.3- BowLeven PLC
9th Jan 20071:27 pmRNSRule 8.3- BowLeven Plc
9th Jan 20071:17 pmRNSRule 8.3- BowLeven Plc
9th Jan 20077:01 amRNSDrilling Update
8th Jan 200711:42 amRNSRule 8.3- Bowleven PLC
5th Jan 20073:48 pmRNSHolding(s) in Company
5th Jan 200710:32 amRNSRule 8.3- Bowleven Plc
5th Jan 20079:59 amBUSEPT Disclosure
4th Jan 200711:27 amBUSEPT Disclosure
3rd Jan 200712:38 pmRNSRule 8.3- BowLeven Plc
3rd Jan 200711:21 amBUSEPT Disclosure
3rd Jan 200710:53 amRNSStatement re Director
2nd Jan 200711:40 amBUSEPT Disclosure
29th Dec 200611:06 amRNSRule 8.3- BowLeven Plc
29th Dec 200610:49 amBUSEPT Disclosure
28th Dec 20062:03 pmRNSRule 8.3- BowLeven PLC
28th Dec 200612:14 pmRNSHolding(s) in Company
28th Dec 200611:58 amRNSHolding(s) in Company
28th Dec 200611:57 amRNSHolding(s) in Company
28th Dec 200611:21 amBUSEPT Disclosure
27th Dec 200612:52 pmRNSRule 8.3- BowLeven Plc
27th Dec 200612:44 pmBUSEPT Disclosure
22nd Dec 200612:32 pmBUSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.